Cardinal Health reaffirms FY2027 non-GAAP EPS growth outlook of 13%-15%
CAH•Cardinal Health reaffirmed fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, implying $12.40 to $12.60, and maintained its long-term growth outlook of 12% to 14%. It also reached a binding letter of intent to extend CVS pharmaceutical distribution services through June 30, 2032.
1. Fiscal 2027 outlook
Cardinal Health reaffirmed its fiscal 2027 non-GAAP EPS growth guidance of 13% to 15%, implying EPS of $12.40 to $12.60. Its long-term non-GAAP EPS growth outlook remains 12% to 14%. The growth assumptions use adjusted fiscal 2026 results and exclude the fiscal 2026 benefit from an IEEPA tariff refund.
2. CVS distribution services
The guidance reaffirmation coincided with a binding letter of intent to extend CVS pharmaceutical distribution services through June 30, 2032.
